Abstract: The present invention relates to compositions and methods of optically imaging tissues or cells using imaging agents have in vivo properties that result in signal-to-background ratios of at least about 1:1. TL is a targeting ligand and n is ?1, 0 or +1.
Type:
Grant
Filed:
February 5, 2010
Date of Patent:
May 5, 2015
Assignees:
Beth Israel Deaconess Medical Center, Georgia State University Research Foundation, Inc.
Abstract: The present invention is based, in part, on our studies of molecular pathways that include the deubiquitinase CYLD. Accordingly, the present invention features, inter alia, nucleic acid constructs that express CYLD or a biologically active variant thereof (e.g., a variant including the catalytic domain), nucleic acids that inhibit the expression of a negative regulator of CYLD (e.g., PDE4B or LNK2), nucleic acids that modulate the expression of downstream CYLD targets (e.g., Akt, by inhibiting or promoting the expression of the downstream target), compositions including one or more of these types of constructs (e.g., pharmaceutical compositions), kits including one or more of the compositions described herein and instructions for use, screening methods to identify therapeutic agents {e.g., anti-inflammatory agents) that upregulate CYLD, downregulate a negative regulatory of CYLD, or modulate (e.g., inhibit) a downstream CYLD target (e.g.
Type:
Application
Filed:
April 9, 2013
Publication date:
March 5, 2015
Applicant:
Georgia State University Research Foundation, Inc.
Abstract: Systems and methods are disclosed with which queries can be sent to various clients of a trusted query network in a trusted query network message. In one embodiment, each registered client receives the message and determines whether or not it will participate in the query. If so, the client adds to the message in a first data round a true response to the query and obfuscation data, and then forwards the message on to the next client (or back to the client that initiated the query if each client has added its data to the message). In a second round, the message is again sent to each participating client, which this time removes its obfuscation data. Once each client has removed its obfuscation data, a final result is obtained that can be sent to each of the clients.
Type:
Grant
Filed:
July 16, 2010
Date of Patent:
December 9, 2014
Assignee:
Georgia State University Research Foundation, Inc.
Inventors:
Richard Baskerville, Art Vandenberg, Daniele Bertolotti, Saravanaraj Duraisamy
Abstract: Disclosed are conjugates that can bind to one or more site on cancer cell surface, for example, surface proteins, compound specific receptors and carbohydrates that comprise the surface of specific cell types. The disclosed conjugates can thereby serve as indicators identifying the presence of cancerous tissue.
Type:
Application
Filed:
July 20, 2012
Publication date:
October 23, 2014
Applicant:
GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION
Abstract: Analyte sensors, methods for producing and using analyte sensors, methods of detecting and/or measuring analyte activity, detecting pH change, and/or, controlling the concentration of an analyte in a system, are disclosed. Embodiments of the analyte sensors according to the disclosure can provide an accurate and convenient method for characterizing analyte activity, detecting pH change, controlling the concentration of an analyte in a system, and the like, in both in vivo and in vitro environments, in particular in living cell imaging.
Type:
Grant
Filed:
October 19, 2011
Date of Patent:
October 21, 2014
Assignee:
Georgia State University Research Foundation, Inc.
Abstract: Embodiments of the present disclosure provide for enzyme sensors, protease sensors, methods for producing and using the enzyme and protease sensors, methods of detecting and/or measuring protease activity, methods for characterizing protease cellular activity, fusion proteins, polynucleotides, and vectors corresponding to the enzyme and protease sensors, kits, and the like.
Type:
Grant
Filed:
March 21, 2013
Date of Patent:
September 30, 2014
Assignee:
Georgia State University Research Foundation, Inc.
Abstract: The invention relates to the innate immune pathway and anti-inflammatory molecules with therapeutic properties. In some embodiments, the invention relates to compounds and pharmaceutical compositions and methods of using the compounds and compositions to treat inflammatory diseases including inflammation associated with auto-immune diseases.
Type:
Grant
Filed:
August 24, 2011
Date of Patent:
September 23, 2014
Assignees:
Emory University, Georgia State University Research Foundation
Inventors:
Susu Zughaier, Ritu Aneja, David S. Stephens
Abstract: Systems and methods for enabling organizations to anonymously share aggregated security assessment results while keeping the raw or private data locally within the organization.
Type:
Grant
Filed:
August 15, 2007
Date of Patent:
July 8, 2014
Assignee:
Georgia State University Research Foundation, Inc.
Inventors:
Richard Baskerville, Martin Grace, Detmar Straub, Carl Stucke, Vijay Vaishnavi, Art Vandenberg, Robert Sainsbury, Guangzhi Zheng, David Bloomquist, Michelle Bellard, Anthony Vance
Abstract: Cyanines which selectively bind to G-quadruplex DNA complexes, particularly quadruplexes expressed in cancer cells, and methods of making and using thereof are described herein. The cyanine can be a symmetrical or unsymmetrical streptocyanine, hemicyanine, closed chain cyanine, or combinations thereof. The cyanine is preferably substituted with one or more groups that minimize or prevent aggregation of the cyanine and/or inhibit binding of the cyanine to duplex DNA. One or more of the cyanines can be formulated with one or more pharmaceutical excipients and/or carrier to prepare pharmaceutical compositions suitable for administration to a patient, particular a human patient. The compounds and compositions described herein can be used to treat diseases or disorders characterized by the expression of G-quadruplex DNA, such as cancer.
Type:
Application
Filed:
July 18, 2012
Publication date:
May 22, 2014
Applicant:
GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION
Abstract: Devices, methods, and systems for an articulated ankle-foot orthosis with a selectively retractable stop are presented. The orthosis includes at least one of a foot mold, a shank mold, a forefoot sensor, a heel sensor, a stop, and a connecting mechanism. The stop is positioned between the foot mold and the shank mold, and the stop is selectively retractable between a closed position and a generally opposing open position that allows plantar flexion of the foot mold during the stance phase of a typical human gait cycle. The connecting mechanism is configured to move the stop from the closed position to the open position in response to a signal from the heel sensor indicating a heel-strike event. The connecting mechanism is also configured to move the stop from the open position back to the closed position in response to a signal from the forefoot sensor indicating a toe-off event.
Type:
Application
Filed:
October 18, 2013
Publication date:
April 24, 2014
Applicant:
Georgia State University Research Foundation, Inc.
Inventors:
Hsin-Chen Daniel Fanchiang, Mark Daniel Geil, Toshiki Nashimoto
Abstract: The 30 amino acid peptide GLP-1 has been integrated into the stable host protein human calbindin D9k. The fusion protein binds to GLP-1R. The fusion protein agents can be useful for both diabetes treatment and GLP-1R receptor targeting MR imaging. The fusion protein comprises a first peptide that selectively binds to a site of a target cell and linked to a second peptide, where the fusion protein is more stable than the first peptide alone and may further comprise a detectable label. The first peptide of the fusion protein may be glucagon-like peptide-1 (GLP-1), glucagon-like peptide-1 (GLP-1)(7-36), or glucagon-like peptide-1 (GLP-1) (9-36), or a conservative variant thereof.
Type:
Grant
Filed:
October 20, 2010
Date of Patent:
April 15, 2014
Assignee:
Georgia State University Research Foundation, Inc.
Abstract: The present disclosure encompasses compounds and compositions that are useful as specific AI-2 antagonists for the control of bacterial quorum sensing. Although the AI-2 antagonists according to the present disclosure may not have bactericidal effect, their ability to attenuate virulence, drug resistance, and/or biofilm formation have therapeutic benefits. In addition, the AI-2 antagonists of the present disclosure can also be used as tools to probe bacterial AI-2 functions. The present disclosure also encompasses methods for inhibiting or attenuating microbial virulence, biofilm formation, and drug resistance. The methods are suitable for preventing bacteria from accruing and forming extensive biofilms that may be a health or hygiene hazard or a physical issue, such as in the blockage of water or fuel lines.
Type:
Grant
Filed:
June 6, 2008
Date of Patent:
February 18, 2014
Assignee:
Georgia State University Research Foundation, Inc.
Abstract: Selective chemosensing agents for hydrogen sulfide are provided. The chemosensing agents can act fast under mild conditions, are chemically stable for long-term storage, are sensitive for detection under near physiological conditions, show a linear concentration-signal relationship within physiologically relevant hydrogen sulfide concentration ranges for easy quantitation, show minimal or no interference by other anions in the blood, and are functional in aqueous solutions and blood plasma.
Type:
Application
Filed:
January 6, 2012
Publication date:
November 14, 2013
Applicant:
GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
Abstract: Anti-angiogenic agents or polypeptides comprising an amino acid segment substantially similar to domain one of CD2 wherein the polypeptide has a ?-sheet formed by two segments. Methods of using such agents and polypeptide are also included.
Type:
Application
Filed:
July 13, 2011
Publication date:
October 24, 2013
Applicant:
Georgia State University Research Foundation
Abstract: Embodiments of the present disclosure provide for analyte sensors, methods for producing and using the analyte sensors, methods of detecting and/or measuring analyte activity, methods for characterizing analyte cellular activity, methods of detecting pH change in a system, method of controlling the concentration of an analyte in a system, fusion proteins, polynucleotides, and vectors corresponding to the analyte sensors, kits, and the like.
Type:
Application
Filed:
April 15, 2013
Publication date:
October 17, 2013
Applicant:
Georgia State University Research Foundation, Inc.
Inventor:
Georgia State University Research Foundation, Inc.
Abstract: A fluorescent sensor and methods for producing and using the fluorescent sensor. Such fluorescent sensors have broad applicability in characterizing cells and organisms, in detecting or measuring various cellular parameters, and in detecting or measuring protein-protein/peptide interactions.
Type:
Grant
Filed:
May 3, 2006
Date of Patent:
September 24, 2013
Assignee:
Georgia State University Research Foundation, Inc.
Abstract: A high operating temperature split-off band infrared (SPIP) detector having a double and/or graded barrier on either side of the emitter is provided. The photodetector may include a first and second barrier and an emitter disposed between the first and second barriers so as to form a heterojunction at each interface between the emitter and the first and second barriers, respectively. The emitter may be of a first semiconductor material having a split-off response to optical signals, while one of the first or the second barriers may include a double barrier having a light-hole energy band level that is aligned with the split-off band energy level of the emitter. In addition, the remaining barrier may be graded.
Type:
Grant
Filed:
February 3, 2010
Date of Patent:
September 10, 2013
Assignee:
Georgia State University Research Foundation, Inc.
Abstract: Embodiments of the present disclosure provide for enzyme sensors, protease sensors, methods for producing and using the enzyme and protease sensors, methods of detecting and/or measuring protease activity, methods for characterizing protease cellular activity, fusion proteins, polynucleotides, and vectors corresponding to the enzyme and protease sensors, kits, and the like.
Type:
Application
Filed:
March 21, 2013
Publication date:
August 8, 2013
Applicant:
Georgia State University Research Foundation, Inc.
Inventor:
Georgia State University Research Foundation, Inc.